Sertraline effectiveness and safety in depressed oncological patients

Supportive Care in Cancer

Volumn 16, Issue 1, 2008, Pages 83-91

  Torta, Riccardo ^a   Siri, Ilaria ^a   Caldera, Paola ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Cancer; Depression; Psychoncology; Sertraline

Indexed keywords

SERTRALINE;

ADULT; AGITATION; ANOREXIA; ANXIETY DISORDER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EXCITEMENT; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SINGLE DRUG DOSE; TREMOR; XEROSTOMIA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTINEOPLASTIC AGENTS; ANXIETY; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SERTRALINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 36949009203     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0269-0     Document Type: Article

References (43)

1. American Psychiatry Association (2000) DSM-IV-TR: diagnostic and statistical manual of mental disorders, text revision, 4th edn. American Psychiatry Association, Washington, DC
2. Ashbury FD, Madlensky L, Raich P et al (2003) Antidepressant prescribing in community cancer care. Support Care Cancer 11(5):278-285
3. Binaschi L, Berra C, Caldera P, Torta R, Mussa A (2006) Somatic, affective and cognitive symptoms for diagnosing mood disorders in cancer patients. Psychooncology 15(S2):176-177
4. Black SA, Markides KS (1999) Depressive symptoms and mortality in older Mexican Americans. Ann Epidemiol 9(1):45-52
5. Derogatis LR, Morrow GR, Fetting J et al (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249(6):751-757
6. Evans DL, McCartney CF, Haggerty JJ Jr, Nemeroff CB, Golden RN, Simon JB, Quade D, Holmes V, Droba M, Mason GA et al (1988) Treatment of depression in cancer patients is associated with better life adaptation: a pilot study. Psychosom Med 50(1):73-76
7. Faller H, Bulzebruck H, Schilling S, Drings P, Lang H (1997) Do psychological factors modify survival of cancer patients? II: results of an empirical study with bronchial carcinoma patients. Qual Life Res 6(2):159-168 (Mar)
8. Fisch MJ, Loehrer PJ, Kristeller J et al (2003) Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21(10):1937-1943
9. Fisch MJ (2004) Treatment of depression in cancer. J Natl Cancer Inst Monographs 32:105-111
10. Goodnick PJ, Hernandez M (2000) Treatment of depression in comorbid medical illness. Expert Opin Pharmacother 1(7):1367-1384
11. Grassi L, Rosti G (1996) Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer. Psychother Psychosom 65(5):246-252
12. Grassi L, Biancosino B, Marmai L, Righi R (2004) Effect of reboxetine on major depressive disorder in breast cancer patients: an open-label study. J Clin Psychiatry 65:4
13. Grassi L, Buda P, Cavana L, Annunziata MA, Torta R, Varetto A (2005) Styles of coping with cancer: the Italian version of the mini-mental adjustment to cancer (MINI-MAC) scale. Psychooncology 14(2):115-124
14. Grassi L, Mangelli L, Fava GA, Grandi S, Ottolini F, Porcelli P, Rafanelli C, Rigatelli M, Sonino N (2007) Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord 101(1-3):251-254
15. Guy W (1976) ECDEU assessment manual for psychopharmacology, revised. US National Institute of Health, Psychopharmacology Research Branch, Rockville, MD, pp 223-244
16. Hawley CJ, Gale TM, Sivakumaran T (2002) Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord 72:177-184
17. Holland JC, Romano SJ, Heiligenstein JH et al (1998) A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 7(4):291-300
18. Insel TR, Charney DS (2003) Research on major depression. JAMA 289:3167-3168
19. McDaniel JS, Musselman DL, Porter MR, Porter MR, Reed DA, Nemeroff CB (1995) Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89-99
20. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Brit J Psychiatry 134:382-389
21. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PLR, Flynn PJ, Hynes HE, Banerjee TK, Kirshner JJ, King DK (2003) Differential effects of paroxetine on fatigue and depression: a randomized double-blind trial from the University of Rochester Cancer Centre Community Clinical Oncology Program. J Clin Oncol 21:4635-4641
22. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961-966
23. Newport DJ, Nemeroff CB (1998) Assessment and treatment of depression in the cancer patient. J Psychosom Res 45:215-237
24. Pezzella G, Moslinger-Gehmayr R, Contu A (2001) Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 70(1):1-10
25. Plouffe L, Trott E, Largoza M et al (1997) An open trial of sertraline for menopausal hot flashes: potential involvement of serotonin in vasomotor instability. Del Med J 69:481-482
26. Preskorn SH (1997) Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 32(Suppl 1):1-21
27. Ryan H, Schofield P, Cockburn J, Butow P, Tattersall M, Turner J, Girgis A, Bandaranayake D, Bowman D (2005) How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care 14:7-15
28. Razavi D, Allilaire JF, Smith M, Salimpour A, Verra M, Desclaux B, Saltel P, Piollet I, Gauvain-Piquard A, Trichard C, Cordier B, Fresco R, Guillibert E, Sechter D, Orth JP, Bouhassira M, Mesters P, Blin P (1996) The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 94:205-210
29. Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5(10):617-625
30. Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, Bushunow P, Qazi R, Smith B (2005) Effect of paroxetine hydrochloride (Paxil®) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89(3):243-249
31. Roth A, Scher H (1998) Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology 7:129-132
32. Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Horning M, Holland PJ, Mandel FS, Clary CM, Burt T (2004) Efficacy, safety and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc 52:86-92
33. Somerset W, Stout SC, Miller AH, Musselman D (2004) Breast cancer and depression. Oncology (Williston Park) 18(8):1021-1034
34. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chronic Dis 34(12):585-597
35. Torta R, Mussa A (eds) (1997) Psiconcologia. Basi biologiche, aspetti clinici ed approcci terapeutici. Centro Scientifico Editore, Torino
36. Torta R, Amodeo L, Berra C, Borio R, Caldera P, Scalabrino A (2003) Lo spettro di impiego degli psicofarmaci in oncologia. Ital J Psychopathol 9 Suppl
37. Torta R (2006) Depression as a systemic disease: the antidepressants spectrum of action. Psychooncology 15(S2):2-3
38. Van Heeringen K, Zivkov M (1996) Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry 169:440-443
39. Watson M, Law M, dos Santos M (1992) Coping with cancer: the Mini-MAC. ICPO, Beaune
40. World Medical Association (2002) Declaration of Helsinki: ethical principles for medical research involving human subject. 52nd WMA General Assembly. Edinburgh, Scotland (October)
41. Wu W, Yamaura T, Murakami K, Murata J, Matsumoto K, Watanabe H, Saiki I (2000) Social isolation stress enhanced liver metastasis of murine colon 26-L5 carcinoma cells by suppressing immune responses in mice. Life Sci 66(19):1827-1838
42. Wu W, Murata J, Hayashi K, Yamaura T, Mitani N, Saiki I (2001) Social isolation stress impairs the resistance of mice to experimental liver metastasis of murine colon 26-L5 carcinoma cells. Biol Pharm Bull 24(7):772-776
43. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370